Adenocarcinoma of Colon Terminated Phase 2 Trials for Gefitinib (DB00317)
Also known as: Adenocarcinoma Colon / Colon Adenocarcinoma / Adenocarcinoma of the Colon
| Indication | Status | Phase |
|---|---|---|
| DBCOND0060083 (Adenocarcinoma of Colon) | Terminated | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT00052585 | Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal Cancer | Treatment |